Professional Summary
Professional Overview
Ryan Selhorn is the Chief Financial Officer at Aytu BioPharma, a leading biopharmaceutical company. With over 18 years of experience in finance, accounting, and business optimization, he brings a wealth of expertise to his current role. Selhorn's industry focus encompasses the pharmaceutical and healthcare sectors, where he has demonstrated a track record of driving financial performance and operational efficiency.
Experience Summary
Current Role
As the Chief Financial Officer at Aytu BioPharma, Selhorn is responsible for overseeing all financial operations, including financial planning, budgeting, reporting, and risk management. He plays a crucial role in developing and executing the company's strategic financial initiatives, ensuring alignment with the organization's long-term goals. Under his leadership, Aytu BioPharma has achieved significant improvements in financial performance, optimizing cost structures and enhancing shareholder value.
Career Progression
Prior to his current role, Selhorn held various leadership positions within Aytu BioPharma, including Executive Vice President of Finance & Business Optimization and Senior Vice President of Finance & Operations for the Consumer Healthcare Division. He has also served as the Vice President and Chief Financial Officer at Innovus Pharmaceuticals, Inc., and the Chief Financial Officer and Chief Accounting Officer at Signature Analytics. Selhorn's early career was marked by his contributions as an Audit Manager and Senior Manager at Grant Thornton LLP, where he gained extensive experience in financial auditing and consulting.
Academic Background
Selhorn holds a Bachelor of Science degree in Accounting from the University of California, San Diego. He is a Certified Public Accountant (CPA) and has continued to expand his expertise through various professional development programs and industry-specific training.
Areas of Expertise
- Financial Management and Strategic Planning
- Financial Reporting and Analysis
- Mergers, Acquisitions, and Business Integration
- Cost Optimization and Process Improvement
- Regulatory Compliance and Risk Management
- Leadership and Team Development
Professional Impact
During his tenure at Aytu BioPharma, Selhorn has spearheaded several strategic initiatives that have had a significant impact on the company's financial performance. He led the successful integration of a major acquisition, driving synergies and enhancing the overall financial position of the organization. Selhorn has also been instrumental in implementing robust financial controls and reporting systems, which have contributed to the company's improved transparency and operational efficiency.
Conclusion
With his extensive experience in the pharmaceutical and healthcare industries, coupled with his strong financial acumen and strategic leadership, Ryan Selhorn is poised to continue driving Aytu BioPharma's financial success and supporting the company's overall growth and expansion efforts.
